Dr. Geoff Goodfellow has been in the healthcare industry since 2001. His primary focus as a board-certified toxicologist and preclinical development manager is to facilitate the development and conduct of nonclinical safety programs for a broad range of drugs and biopharmaceuticals. Dr. Goodfellow has been involved in the design, development, and execution of protocols for hundreds of studies including general toxicology, safety pharmacology, PK/ADME, genotoxicity, reproductive and developmental toxicity, and carcinogenicity studies.
Dr. Goodfellow also assists companies by preparing or reviewing preclinical drug development strategies, carrying out gap analyses for drug or pharmaceutical products, biologics, drug delivery systems, natural health products, and conducting due diligence reviews to evaluate preclinical data and/or technology platforms. Dr. Goodfellow is acknowledged as a professional writer in the area of toxicology. As a regulatory toxicologist, he evaluates preclinical data for authoring and preparation of regulatory submissions (e.g., INDs, CTAs, IMPDs) and has represented clients at meetings with regulatory agencies (U.S. FDA, Health Canada).
Experience Highlights
Prepares nonclinical testing strategies and data gap analyses for pharmaceuticals and biologics covering a broad range of therapeutic areas.
Manages clients, CROs, and subcontractors to oversee quality, science, timelines, and budgets for nonclinical studies.
Monitors nonclinical studies for scientific integrity and compliance with Good Laboratory Practices.
Analyzes and interprets toxicological data in order to integrate complex scientific concepts into client-ready documents.
Toxicology expert for regulatory submissions.
Published author in the area of nonclinical drug development.
Represented sponsors successfully at meetings with U.S. FDA and Health Canada.
Education and Professional Qualifications
Ph.D., Pharmacology, University of Toronto
M.Sc., Pharmacology, University of Toronto
B.Sc. (Honours) in Life Sciences, Queen’s University
DABT, Diplomate of the American Board of Toxicology
ERT, European Registered Toxicologist
Professional Affiliations
American College of Toxicology
Society of Toxicology
Join Our Team
Intrinsik Corp., is a dynamic science-based consulting firm. We are eagerly interested in professionals to add to our accredited staff base. Intrinsik is strongly committed to our employees by ensuring mentoring, training and advancement for those with a drive to succeed. Our areas of expertise include and are not limited to toxicology, human health and environmental risk assessment, biology, multi-media exposure modeling, environmental science, and risk management.
Diversity is not only part of our company’s culture, it is a core business strategy. We are building a workforce that is representative of our society, and our programs and policies are designed to foster diversity and inclusion.
AODA Declaration
Our goal is to create an environment that is inclusive to all members of the community. Intrinsik Corp., focuses on identifying, removing, and preventing barriers for persons with disabilities, and our policy complies with the Accessibility for Ontarians with Disabilities Act, 2005 (AODA).
How Can We Help?
Our scientists have the expertise to address your complex
toxicological health and environmental issues, including product
development and business risks to avoid scientific and regulatory delays.